Although heterogeneity became evident for some parameters, meta-analysis of these data using a random effects model revealed an association between high expression of survivin and advanced UICC stages (OR: 2.24; 95% CI: 1.56–3.21; p < 0.0001; I2 = 53%), T stage (OR: 1.57; 95% CI: 1.14–2.18; p = 0.006; I2 = 0%), poor histological differentiation (OR: 1.66; 95% CI: 1.20–2.29; p = 0.002; I2 = 37%), and the presence of lymph node metastasis (OR: 1.95; 95% CI: 1.36–2.78; p = 0.0003; I2 = 66%) (Table 4). The gene discussed is BIRC5; the disease is metastatic malignant neoplasm in the lymph nodes.